1/3
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
OTC - EHC
LEVONELLE - Levonorgestrel (LNG) 1.5mg
Prevents ovulation and fertilisation and (post-ovulation?) - discourages implantation
Licensed OTC for ages 16 and over
ELLAONE - Ulipristal acetate (UPA) 30mg
Delays ovulation
Alterations to endometrium
Licensed OTC for all women of childbearing age
Efficacy and ADRs
Levonelle
Licensed up to 72 hours
Overall efficacy = 84%
95% (<24hrs)
85% (<25-48hrs)
58% (49-72%hrs)
ADRs
Headache, nausea lower abdominal pain, breast tenderness, irregular bleeding, increased risk of ectopic pregnancy
ELLAONE (first line)
Slightly higher efficacy and lower pregnancy rate in 0-72hrs to LNG
48-120hrs - 2% pregnancy rate
Efficacy of UPA reduced if any progesterone taken in the 7 days post UPA - theoretical risk
ADRs
Headache, nausea, abdominal pain, irregular bleeding, dysmenorrhea
Emergency Contraception
Copper-bearing IUD (GP/GUM clinics)
Non-hormonal!!!!!!
Fitting: STI screen and/or prophylactic antibiotics
Risks/ADRs: cramping, bleeding, heavier/longer/painful periods, bacterial infection, thrush, ectopic pregnancy
Indication for EHC
After UPSI on any day of menstrual cycle
UPSI in 28 days following use of enzyme-inducing drugs (anti-seizure)
UPSI from 21 days postpartum
UPSI from 5 days post-abortion/miscarriage/ectopic pregnancy
After ejaculation onto external genitalia
UPSI before new contraception is effective
After contraceptive failure
Split condom
Missed pill
DDI with hormonal contraception
Delayed contraceptive implant or injection
Detached contraceptive patch
7 days prior to IUD/IUS being dislodged/removed
Dislodged/early removal diaphragm